Publication | Closed Access

The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display α-/β-Adrenoceptor antagonist and long-Acting antihypertensive activities

Molecular PharmacologyHypertensionMedicineAntihypertensive Therapy4-Phenyl OxypropanolaminePharmacotherapyPharmacologyα-/β-Adrenoceptor AntagonistLong-acting Antihypertensive ActivitiesAlpha-adrenergic Pharmacology